122 related articles for article (PubMed ID: 35373672)
1. Should we adjudicate outcomes in stroke trials? A systematic review.
Godolphin PJ; Bath PM; Montgomery AA
Int J Stroke; 2023 Feb; 18(2):154-162. PubMed ID: 35373672
[TBL] [Abstract][Full Text] [Related]
2. Outcome Assessment by Central Adjudicators Versus Site Investigators in Stroke Trials: A Systematic Review and Meta-Analysis.
Godolphin PJ; Bath PM; Algra A; Berge E; Brown MM; Chalmers J; Duley L; Eliasziw M; Gregson J; Greving JP; Hankey GJ; Hosomi N; Johnston SC; Patsko E; Ranta A; Sandset PM; Serena J; Weimar C; Montgomery AA;
Stroke; 2019 Aug; 50(8):2187-2196. PubMed ID: 33755494
[TBL] [Abstract][Full Text] [Related]
3. Cost-benefit of outcome adjudication in nine randomised stroke trials.
Godolphin PJ; Bath PM; Algra A; Berge E; Chalmers J; Eliasziw M; Hankey GJ; Hosomi N; Ranta A; Weimar C; Woodhouse LJ; Montgomery AA
Clin Trials; 2020 Oct; 17(5):576-580. PubMed ID: 32650688
[TBL] [Abstract][Full Text] [Related]
4. Do we need to adjudicate major clinical events?
Granger CB; Vogel V; Cummings SR; Held P; Fiedorek F; Lawrence M; Neal B; Reidies H; Santarelli L; Schroyer R; Stockbridge NL; Feng Zhao
Clin Trials; 2008; 5(1):56-60. PubMed ID: 18283081
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC
JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536
[TBL] [Abstract][Full Text] [Related]
7. Central adjudication of serious adverse events did not affect trial's safety results: Data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.
Godolphin PJ; Montgomery AA; Woodhouse LJ; Bereczki D; Berge E; Collins R; Díez-Tejedor E; Gommans J; Lees KR; Ozturk S; Phillips S; Pocock S; Prasad K; Szatmari S; Wang Y; Bath PM; Sprigg N;
PLoS One; 2018; 13(11):e0208142. PubMed ID: 30475912
[TBL] [Abstract][Full Text] [Related]
8. Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.
Easton JD; Denison H; Evans SR; Knutsson M; Amarenco P; Albers GW; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KL; Johnston SC;
Int J Stroke; 2019 Dec; 14(9):908-914. PubMed ID: 31092152
[TBL] [Abstract][Full Text] [Related]
9. A comparison of approaches for adjudicating outcomes in clinical trials.
Kahan BC; Feagan B; Jairath V
Trials; 2017 Jun; 18(1):266. PubMed ID: 28595589
[TBL] [Abstract][Full Text] [Related]
10. Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial.
van der Ende NAM; Roozenbeek B; Berkhemer OA; Koudstaal PJ; Boiten J; van Dijk EJ; Roos YBWEM; van Oostenbrugge RJ; Majoie CBLM; van Zwam W; Lingsma HF; van der Lugt A; Dippel DWJ;
Stroke; 2022 Jan; 53(1):61-69. PubMed ID: 34607469
[TBL] [Abstract][Full Text] [Related]
11. A hybrid automated event adjudication system for clinical trials.
Yuan F; Bosch J; Eikelboom J; Dagenais GR; Connolly S; Belanger J; Marsden T; Tang C; Swaminathan B; Renters M; Dyal L; Bangdiwala SI
Clin Trials; 2023 Apr; 20(2):166-175. PubMed ID: 36734212
[TBL] [Abstract][Full Text] [Related]
12. Central vs site outcome adjudication in the IRIS trial.
Forman R; Viscoli CM; Bath PM; Furie KL; Guarino P; Inzucchi SE; Young L; Kernan WN
J Stroke Cerebrovasc Dis; 2022 Sep; 31(9):106667. PubMed ID: 35901589
[TBL] [Abstract][Full Text] [Related]
13. Adjudication of cardiovascular events in patients with chronic obstructive pulmonary disease: SUMMIT trial.
Wise RA; Anderson JA; Amarenco P; Cowans NJ; Crim C; Denvir MA; Gomez CR; Jones MP; Morris A; Niewoehner D; Yates JC
Clin Trials; 2020 Aug; 17(4):430-436. PubMed ID: 32441114
[TBL] [Abstract][Full Text] [Related]
14. Outcome assessment by central adjudicators in randomised stroke trials: Simulation of differential and non-differential misclassification.
Godolphin PJ; Bath PM; Partlett C; Berge E; Brown MM; Eliasziw M; Sandset PM; Serena J; Montgomery AA
Eur Stroke J; 2020 Jun; 5(2):174-183. PubMed ID: 32637651
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events: A Secondary Analysis of the COMPASS Trial.
Gaba P; Bhatt DL; Dagenais GR; Bosch J; Maggioni AP; Widimsky P; Leong D; Fox KAA; Yusuf S; Eikelboom JW;
JAMA Netw Open; 2022 Nov; 5(11):e2243201. PubMed ID: 36409491
[TBL] [Abstract][Full Text] [Related]
16. Improving the efficiency of stroke trials: feasibility and efficacy of group adjudication of functional end points.
McArthur KS; Johnson PC; Quinn TJ; Higgins P; Langhorne P; Walters MR; Weir CJ; Dawson J; Lees KR;
Stroke; 2013 Dec; 44(12):3422-8. PubMed ID: 24052508
[TBL] [Abstract][Full Text] [Related]
17. Phone and Video-Based Modalities of Central Blinded Adjudication of Modified Rankin Scores in an Endovascular Stroke Trial.
López-Cancio E; Salvat M; Cerdà N; Jiménez M; Codas J; Llull L; Boned S; Cano LM; Lara B; Molina C; Cobo E; Dávalos A; Jovin TG; Serena J;
Stroke; 2015 Dec; 46(12):3405-10. PubMed ID: 26542697
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.
Pogue J; Walter SD; Yusuf S
Clin Trials; 2009 Jun; 6(3):239-51. PubMed ID: 19528133
[TBL] [Abstract][Full Text] [Related]
19. Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial.
Hata J; Arima H; Zoungas S; Fulcher G; Pollock C; Adams M; Watson J; Joshi R; Kengne AP; Ninomiya T; Anderson C; Woodward M; Patel A; Mancia G; Poulter N; MacMahon S; Chalmers J; Neal B;
PLoS One; 2013; 8(2):e55807. PubMed ID: 23390553
[TBL] [Abstract][Full Text] [Related]
20. Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.
Scirica BM; Im K; Murphy SA; Kuder JF; Rodriguez DA; Lopes RD; Green JB; Ruff CT; Sabatine MS
Clin Cardiol; 2022 Jul; 45(7):794-801. PubMed ID: 35715946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
